MYELOFIBROSIS; ANEMIA
Clinical trials for MYELOFIBROSIS; ANEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELOFIBROSIS; ANEMIA trials appear
Sign up with your email to follow new studies for MYELOFIBROSIS; ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Old HIV drug may help bone marrow make red blood cells in rare cancer
Disease control Recruiting nowThis early-phase trial tests whether nelfinavir, a drug originally used for HIV, can improve anemia in people with myelofibrosis — a rare bone marrow cancer. The study aims to see if the drug helps the body deliver iron to the bone marrow to make more red blood cells. About 10 ad…
Matched conditions: MYELOFIBROSIS; ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug aims to free blood cancer patients from transfusions
Disease control Recruiting nowThis study is testing an experimental drug called DISC-0974 in about 150 adults with myelofibrosis or myelodysplastic syndrome (MDS) who also have anemia. The goal is to see if the drug can help patients produce enough red blood cells so they no longer need regular blood transfus…
Matched conditions: MYELOFIBROSIS; ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New study aims to map Real-World care for rare bone marrow disease
Knowledge-focused Recruiting nowThis study is a registry that will follow about 200 people in Germany who have myelofibrosis (a rare bone marrow disorder) and anemia. It does not test a new treatment but instead collects information on which therapies patients receive, how their blood counts and spleen size res…
Matched conditions: MYELOFIBROSIS; ANEMIA
Sponsor: iOMEDICO AG • Aim: Knowledge-focused
Last updated May 17, 2026 00:45 UTC